Debt-to-equity of Celldex Therapeutics, Inc. from 30 Jun 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Celldex Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2012 to 30 Sep 2025.
  • Celldex Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 6.2%, a 32% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Celldex Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 6.2% +1.5% +32% 30 Sep 2025
Q2 2025 5.4% -0.28% -4.9% 30 Jun 2025
Q1 2025 5% -1.9% -27% 31 Mar 2025
Q4 2024 4.6% -4.5% -50% 31 Dec 2024
Q3 2024 4.7% -4.2% -47% 30 Sep 2024
Q2 2024 5.7% -1.8% -24% 30 Jun 2024
Q1 2024 6.8% -1.4% -17% 31 Mar 2024
Q4 2023 9% +1.1% +14% 31 Dec 2023
Q3 2023 9% +1.6% +22% 30 Sep 2023
Q2 2023 7.5% +0.55% +7.9% 30 Jun 2023
Q1 2023 8.2% +1.5% +22% 31 Mar 2023
Q4 2022 8% +0.18% +2.3% 31 Dec 2022
Q3 2022 7.4% -2.1% -22% 30 Sep 2022
Q2 2022 7% -5.2% -43% 30 Jun 2022
Q1 2022 6.7% -4.7% -41% 31 Mar 2022
Q4 2021 7.8% -5.9% -43% 31 Dec 2021
Q3 2021 9.5% -7% -42% 30 Sep 2021
Q2 2021 12% -9.3% -43% 30 Jun 2021
Q1 2021 11% -20% -63% 31 Mar 2021
Q4 2020 14% -17% -55% 31 Dec 2020
Q3 2020 16% -12% -43% 30 Sep 2020
Q2 2020 21% -7.9% -27% 30 Jun 2020
Q1 2020 31% -0.8% -2.5% 31 Mar 2020
Q4 2019 30% -4.5% -13% 31 Dec 2019
Q3 2019 29% -7.3% -20% 30 Sep 2019
Q2 2019 29% -11% -27% 30 Jun 2019
Q1 2019 32% -11% -26% 31 Mar 2019
Q4 2018 35% -8.6% -20% 31 Dec 2018
Q3 2018 36% -9.9% -22% 30 Sep 2018
Q2 2018 40% +0.54% +1.4% 30 Jun 2018
Q1 2018 43% +12% +37% 31 Mar 2018
Q4 2017 43% +20% +84% 31 Dec 2017
Q3 2017 46% +30% +188% 30 Sep 2017
Q2 2017 39% +25% +172% 30 Jun 2017
Q1 2017 31% +18% +136% 31 Mar 2017
Q4 2016 24% +12% +108% 31 Dec 2016
Q3 2016 16% +4.9% +44% 30 Sep 2016
Q2 2016 14% +2.7% +23% 30 Jun 2016
Q1 2016 13% +1% +8.5% 31 Mar 2016
Q4 2015 11% -1.3% -10% 31 Dec 2015
Q3 2015 11% +0.54% +5.1% 30 Sep 2015
Q2 2015 12% +1.1% +10% 30 Jun 2015
Q1 2015 12% +1.9% +18% 31 Mar 2015
Q4 2014 13% +0.88% +7.5% 31 Dec 2014
Q3 2014 11% -5.8% -35% 30 Sep 2014
Q2 2014 11% -8.5% -44% 30 Jun 2014
Q1 2014 10% -14% -58% 31 Mar 2014
Q4 2013 12% -18% -60% 31 Dec 2013
Q3 2013 16% -15% -48% 30 Sep 2013
Q2 2013 19% -13% -41% 30 Jun 2013
Q1 2013 24% 31 Mar 2013
Q4 2012 30% 31 Dec 2012
Q3 2012 32% 30 Sep 2012
Q2 2012 32% 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.